Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena Cortes-Flores

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Frontiers in Aging Neuroscience|June 3, 2026
Anti-inflammatory and immunomodulatory therapies are associated with reduced risk of age-associated neurodegenerative diseases: impact of sex and treatment durationHelena Cortes-Flores, Georgina Torrandell-Haro, Roberta Diaz Brinton
Frontiers in Psychiatry|March 15, 2024
Association between CNS-active drugs and risk of Alzheimer's and age-related neurodegenerative diseasesHelena Cortes-Flores, Georgina Torrandell-Haro, Roberta Diaz Brinton
Medrxiv : the Preprint Server for Health Sciences|March 13, 2026
Immunotherapies for risk reduction in age-associated neurodegenerative diseases: impact of sex and treatment durationHelena Cortes-Flores, Georgina Torrandell-Haro, Roberta Diaz Brinton
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentHelena Cortes-Flores, Georgina Torrandell-Haro, Roberta Diaz Brinton
Iscience|November 29, 2023
Breast cancer therapies reduce risk of Alzheimer's disease and promote estrogenic pathways and action in brainGregory L Branigan, Georgina Torrandell-Haro, Shuhua Chen, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Frontiers in Aging Neuroscience|June 3, 2026
Anti-inflammatory and immunomodulatory therapies are associated with reduced risk of age-associated neurodegenerative diseases: impact of sex and treatment durationHelena Cortes-Flores, Georgina Torrandell-Haro, Roberta Diaz Brinton
Frontiers in Psychiatry|March 15, 2024
Association between CNS-active drugs and risk of Alzheimer's and age-related neurodegenerative diseasesHelena Cortes-Flores, Georgina Torrandell-Haro, Roberta Diaz Brinton
Medrxiv : the Preprint Server for Health Sciences|March 13, 2026
Immunotherapies for risk reduction in age-associated neurodegenerative diseases: impact of sex and treatment durationHelena Cortes-Flores, Georgina Torrandell-Haro, Roberta Diaz Brinton
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentHelena Cortes-Flores, Georgina Torrandell-Haro, Roberta Diaz Brinton
Iscience|November 29, 2023
Breast cancer therapies reduce risk of Alzheimer's disease and promote estrogenic pathways and action in brainGregory L Branigan, Georgina Torrandell-Haro, Shuhua Chen, et al.
Pageof 1